Todd Harrison is the Founding Partner of CB1 and the Chief Investment Officer. 

CB1 Capital is an investment manager and advisor that specializes in the supply chain of cannabinoid-based wellness solutions, products and therapies that address a wide range of unmet medical conditions, or have commercial use-cases.

Topics: Cannabis 1.0 to 2.0 • SAFE Banking Act • Regulatory Arbitrage • US Opportunity

420: Todd Harrison of CB1 Capital

A Podcast Broadcasted From Contrarian Island • Bitcoin • Cannabis

Society & Culture

Personal Journals

History

Philosophy

Places & Travel

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Entrepreneurship

Documentary

Delivering the week's top stories in the cannabis markets!

420 Recap: Top Stories In The Cannabis Market (10.4.19)

Narbe Alexandrian is the CEO of Canopy Rivers.

Canopy Rivers ($RIV $CNPOF) is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED,NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

420: Narbe Alexandrian CEO of Canopy Rivers

Brady Cobb is the CEO of Sol Global Investments.

SOL Global is an international investment company with a focus on, but not limited to, cannabis and cannabis-related companies in legal U.S. states, the hemp and CBD marketplaces and the emerging European cannabis and hemp marketplaces. Its strategic investments and partnerships across cultivation, distribution, and retail complement the company's R&D program with the University of Miami. It is this comprehensive approach that is positioning SOL Global as a future frontrunner in the United States' medical cannabis industry.

420: Brady Cobb CEO of SOL Global

Kyle Kingsley is the CEO of Vireo Health. 

Vireo Health International, Inc.'s mission is to build the cannabis company of the future by bringing the best of medicine, engineering, and science to the cannabis industry. Vireo's physician-led team of more than 350 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, and Rhode Island.

420: Todd Harrison of CB1 Capital

Download our free app to listen on your phone